Showing results (3131-3140 of 9,925) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|April 21, 2015
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCTE Biagi, D Zama, C Nastasi, et al.
Bone Marrow Transplantation|April 21, 2015
Meibography and meibomian gland measurements in ocular graft-versus-host diseaseL A Engel, S Wittig, F Bock, et al.
Bone Marrow Transplantation|April 24, 2020
Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)Charlotte Laurent, Zora Marjanovic, Laure Ricard, et al.
Bone Marrow Transplantation|May 15, 2020
The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endotheliumJulia Martinez-Sanchez, Marta Palomo, Sergi Torramade-Moix, et al.
Bone Marrow Transplantation|June 1, 2020
Value and affordability of CAR T-cell therapy in the United StatesSalvatore Fiorenza, David S Ritchie, Scott D Ramsey, et al.
Bone Marrow Transplantation|September 3, 2021
Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in childrenThomas Pincez, Raoul Santiago, Henrique Bittencourt, et al.
Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.
Bone Marrow Transplantation|July 14, 2015
Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2F V Michelis, H A Messner, E G Atenafu, et al.
Bone Marrow Transplantation|June 2, 2015
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipientsB K Hamilton, A D Law, L Rybicki, et al.
Bone Marrow Transplantation|June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMTJ R Passweg, M Labopin, J Cornelissen, et al.
Pageof 993